• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

普通外科静脉血栓栓塞风险与预防的教育及临床药师主导的管理策略

Education and clinical pharmacist-led management strategies for the risk and prophylaxis of venous thromboembolism in general surgery.

作者信息

Kiracı Zeynep Karaburç, Yalçın Nadir, Cennet Ömer, Demirkan Kutay, Yorgancı Kaya

机构信息

Department of Clinical Pharmacy, Faculty of Pharmacy, Hacettepe University, Ankara, 06230, Türkiye.

Department of General Surgery, Faculty of Medicine, Hacettepe University, Ankara, 06230, Türkiye.

出版信息

Thromb J. 2023 Aug 9;21(1):86. doi: 10.1186/s12959-023-00530-2.

DOI:10.1186/s12959-023-00530-2
PMID:37559115
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10413499/
Abstract

BACKGROUND

Despite the risks of venous thromboembolism (VTE) in surgical patients are well defined, primary thromboprophylaxis (TP) can be neglected. The aim of this study was to evaluate the risk of VTE and appropriateness of TP and to assess the effects of education and clinical pharmacy (CP) services.

METHODS

This study was conducted in a total of 3 periods (n = 800): pre-education (n = 340), post-education (n = 269) and CP intervention period (n = 191) and the risk of VTE and the appropriateness of TP were evaluated. At the end of pre-education period, patients were re-evaluated after education was given about the guidelines on TP and an educative poster was posted in the services (post-education period). During the CP intervention period, the CP made recommendations in terms of optimal TP use to the physicians in charge.

RESULTS

While there was no significant difference in the optimal TP rate administered to the patients before and after education (138/340, 40.6% vs. 122/269, 45.4%; p = 0.238); this rate was increased to 113/191 (59.2%) in the CP intervention period (p = 0.004). High-risk patients who received one type of TP constituted the majority of patients who did not receive optimal TP. While the ratio of high-risk patients undergoing a single type of TP in the pre- and post-education periods (104/340, 30.6% vs. 83/269, 30.9%), was similar (p = 0.819); with the CP interventions, this rate was reduced to 35/191 (18.3%) (p = 0.001).

CONCLUSION

Even though education has positive influence on surgeons, the implementation of CP practices is more effective especially in terms of maintaining optimal TP.

摘要

背景

尽管手术患者发生静脉血栓栓塞症(VTE)的风险已明确,但一级血栓预防(TP)仍可能被忽视。本研究旨在评估VTE风险及TP的适宜性,并评估教育和临床药学(CP)服务的效果。

方法

本研究共分3个阶段(n = 800):教育前(n = 340)、教育后(n = 269)和CP干预期(n = 191),评估VTE风险及TP的适宜性。在教育前期结束时,在就TP指南进行教育并在服务处张贴教育海报后(教育后期)对患者进行重新评估。在CP干预期,CP就最佳TP使用向主管医生提出建议。

结果

教育前后给予患者的最佳TP率无显著差异(138/340,40.6%对122/269,45.4%;p = 0.238);但在CP干预期该率增至113/191(59.2%)(p = 0.004)。接受单一类型TP的高危患者占未接受最佳TP患者的大多数。教育前和教育后期接受单一类型TP的高危患者比例相似(104/340,30.6%对83/269,30.9%)(p = 0.819);通过CP干预,该率降至35/191(18.3%)(p = 0.001)。

结论

尽管教育对外科医生有积极影响,但CP措施的实施更有效,尤其是在维持最佳TP方面。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b80/10413499/d35d1b849ca0/12959_2023_530_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b80/10413499/d35d1b849ca0/12959_2023_530_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b80/10413499/d35d1b849ca0/12959_2023_530_Fig1_HTML.jpg

相似文献

1
Education and clinical pharmacist-led management strategies for the risk and prophylaxis of venous thromboembolism in general surgery.普通外科静脉血栓栓塞风险与预防的教育及临床药师主导的管理策略
Thromb J. 2023 Aug 9;21(1):86. doi: 10.1186/s12959-023-00530-2.
2
Interventions for implementation of thromboprophylaxis in hospitalized medical and surgical patients at risk for venous thromboembolism.对有静脉血栓栓塞风险的住院内科和外科患者实施血栓预防的干预措施。
Cochrane Database Syst Rev. 2013 Jul 16(7):CD008201. doi: 10.1002/14651858.CD008201.pub2.
3
Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism.对有静脉血栓栓塞风险的住院患者实施血栓预防的干预措施。
Cochrane Database Syst Rev. 2018 Apr 24;4(4):CD008201. doi: 10.1002/14651858.CD008201.pub3.
4
Implementation of a Perioperative Venous Thromboembolism Prophylaxis Program for Patients Undergoing Radical Cystectomy on an Enhanced Recovery After Surgery Protocol.在加速康复外科方案下接受根治性膀胱切除术患者的围手术期静脉血栓栓塞症预防方案的实施。
Eur Urol Focus. 2020 Jan 15;6(1):74-80. doi: 10.1016/j.euf.2018.08.025. Epub 2018 Sep 15.
5
Cost-effectiveness analysis of doctor-pharmacist collaborative prescribing for venous thromboembolism in high risk surgical patients.高危手术患者静脉血栓栓塞症医生-药师联合处方的成本效益分析
BMC Health Serv Res. 2018 Oct 1;18(1):749. doi: 10.1186/s12913-018-3557-0.
6
Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada.加拿大急性病内科患者静脉血栓栓塞预防措施使用情况的多中心评估。
Thromb Res. 2007;119(2):145-55. doi: 10.1016/j.thromres.2006.01.011. Epub 2006 Mar 3.
7
Evaluation and management of thromboprophylaxis in Moroccan hospitals at national level: the Avail-MoNa study.摩洛哥全国医院血栓预防评估与管理:Avail-MoNa 研究。
J Thromb Thrombolysis. 2018 Jul;46(1):113-119. doi: 10.1007/s11239-018-1657-7.
8
Improving thromboprophylaxis in the medical inpatients: The role of the resident in an academic hospital.改善住院内科患者的血栓预防:住院医师在学术型医院中的作用。
Phlebology. 2023 Mar;38(2):91-95. doi: 10.1177/02683555221147472. Epub 2022 Dec 20.
9
Effect of a clinical pharmacy education program on improvement in the quantity and quality of venous thromboembolism prophylaxis for medically ill patients.临床药学教育项目对改善内科疾病患者静脉血栓栓塞预防措施的数量和质量的影响。
J Manag Care Pharm. 2005 Nov-Dec;11(9):755-62. doi: 10.18553/jmcp.2005.11.9.755.
10
Adherence to Venous Thromboprophylaxis Guidelines for Medical and Surgical Inpatients of Teaching Hospitals, Shiraz-Iran.伊朗设拉子教学医院内科和外科住院患者静脉血栓预防指南的依从性
Tanaffos. 2015;14(1):17-26.

引用本文的文献

1
The nature of inquiries and responses in clinical pharmacy teleconsultation service: a retrospective study from Türkiye.临床药学远程会诊服务中咨询与回复的性质:来自土耳其的一项回顾性研究。
J Pharm Policy Pract. 2025 May 30;18(1):2509860. doi: 10.1080/20523211.2025.2509860. eCollection 2025.
2
Evaluation of deep vein thrombosis prophylaxis use in a Northwest Ethiopian medical ward: an observational follow-up study.埃塞俄比亚西北部一个医疗病房中深静脉血栓形成预防措施使用情况的评估:一项观察性随访研究。
Front Med (Lausanne). 2025 Mar 21;12:1468190. doi: 10.3389/fmed.2025.1468190. eCollection 2025.
3
Development of a Predictive Nomogram Model for Early Deep Vein Thrombosis in Postoperative Spontaneous Intracerebral Hemorrhage Patients.

本文引用的文献

1
Perioperative Venous Thromboembolism Prophylaxis.围手术期静脉血栓栓塞症预防。
Mayo Clin Proc. 2020 Dec;95(12):2775-2798. doi: 10.1016/j.mayocp.2020.06.015.
2
Comparison of 2013 and 2009 versions of Caprini risk assessment models for predicting VTE in Chinese cancer patients: a retrospective study.2013 版与 2009 版 Caprini 风险评估模型预测中国癌症患者 VTE 的比较:一项回顾性研究。
J Thromb Thrombolysis. 2020 Aug;50(2):446-451. doi: 10.1007/s11239-020-02038-2.
3
Completion of the Updated Caprini Risk Assessment Model (2013 Version).
术后自发性脑出血患者早期深静脉血栓形成预测列线图模型的开发
Int J Gen Med. 2024 Oct 18;17:4793-4803. doi: 10.2147/IJGM.S484611. eCollection 2024.
4
Characterizing medication safety incidents in surgical patients: a retrospective cross-sectional analysis of incident reports.外科患者用药安全事件特征分析:对事件报告的回顾性横断面分析
Ther Adv Drug Saf. 2024 Sep 14;15:20420986241271881. doi: 10.1177/20420986241271881. eCollection 2024.
5
The effect of pharmacist-led interventions on the appropriateness and clinical outcomes of anticoagulant therapy: a systematic review and meta-analysis.药师主导的干预措施对抗凝治疗的适宜性和临床结局的影响:系统评价和荟萃分析。
Eur Heart J Qual Care Clin Outcomes. 2024 Sep 13;10(6):488-506. doi: 10.1093/ehjqcco/qcae045.
6
Effect of pharmacist care on clinical outcomes and therapy optimization in perioperative settings: A systematic review.药剂师护理对围手术期临床结局及治疗优化的影响:一项系统评价
Am J Health Syst Pharm. 2024 Dec 16;82(1):44-73. doi: 10.1093/ajhp/zxae177.
7
Efficacy and safety of direct oral anticoagulants versus low-molecular-weight heparin for thromboprophylaxis after cancer surgery: a systematic review and meta-analysis.直接口服抗凝剂与低分子量肝素预防癌症手术后血栓形成的疗效和安全性:系统评价和荟萃分析。
World J Surg Oncol. 2024 Feb 26;22(1):69. doi: 10.1186/s12957-024-03341-5.
更新后的卡普兰风险评估模型(2013 年版)的完成。
Clin Appl Thromb Hemost. 2019 Jan-Dec;25:1076029619838052. doi: 10.1177/1076029619838052.
4
VTE Risk Profiles and Prophylaxis in Medical and Surgical Inpatients: The Identification of Chinese Hospitalized Patients' Risk Profile for Venous Thromboembolism (DissolVE-2)-A Cross-sectional Study.内科和外科住院患者的 VTE 风险特征和预防:中国住院患者静脉血栓栓塞症风险特征的识别(DissolVE-2)-一项横断面研究。
Chest. 2019 Jan;155(1):114-122. doi: 10.1016/j.chest.2018.09.020. Epub 2018 Oct 6.
5
Prevalence of venous thromboembolism risk factors and prophylactic adequacy among general surgical patients in a tertiary care hospital.三级护理医院普通外科患者静脉血栓栓塞危险因素的患病率及预防措施的充分性
Indian Heart J. 2016 Jul-Aug;68(4):513-8. doi: 10.1016/j.ihj.2015.12.003. Epub 2016 Jan 12.
6
Effectiveness of Intermittent Pneumatic Compression Devices for Venous Thromboembolism Prophylaxis in High-Risk Surgical Patients: A Systematic Review.间歇性气动压迫装置对高危手术患者预防静脉血栓栓塞的有效性:一项系统评价
J Arthroplasty. 2016 Feb;31(2):524-32. doi: 10.1016/j.arth.2015.09.043. Epub 2015 Oct 29.
7
Venous thromboembolism risk assessment, prophylaxis practices and interventions for its improvement (AVAIL-ME Extension Project, Iran).静脉血栓栓塞风险评估、预防措施及其改进干预(伊朗AVAIL-ME扩展项目)
Thromb Res. 2014 Apr;133(4):567-73. doi: 10.1016/j.thromres.2014.01.006. Epub 2014 Jan 11.
8
Role of the pharmacist in achieving performance measures to improve the prevention and treatment of venous thromboembolism.药师在实现绩效措施以改善静脉血栓栓塞症预防和治疗中的作用。
Pharmacotherapy. 2013 Jun;33(6):650-64. doi: 10.1002/phar.1244. Epub 2013 Apr 1.
9
Venous thromboprophylaxis in general surgery ward admissions: strategies for improvement.普通外科住院患者的静脉血栓栓塞症预防:改进策略。
Int J Qual Health Care. 2012 Dec;24(6):649-56. doi: 10.1093/intqhc/mzs052. Epub 2012 Aug 14.
10
Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.静脉血栓栓塞症的抗血栓治疗:《抗血栓治疗与血栓预防,第 9 版》:美国胸科医师学会循证临床实践指南。
Chest. 2012 Feb;141(2 Suppl):e419S-e496S. doi: 10.1378/chest.11-2301.